Skip to main content



NCI Header
The Cancer Genome Atlas

Search GO



Pilot Project To Map Three Cancers
  More information

Map of TCGA Components
  Click here to view a map of TCGA Components.

National Cancer Institute National Human Genome Research Institute

I News and Announcements

News Releases and Announcements

January 8, 2009

New* NCI Announces New Funding to Support TCGA Genome Characterization Centers and Genome Data Analysis Centers



September 4, 2008

The Cancer Genome Atlas Reports First Results of Comprehensive Study of Brain Tumors: Large-Scale Effort Identifies New Genetic Mutations, Core Pathways



July 2, 2007

The Cancer Genome Atlas Awards Funds for Technology Development



November 20, 2006

NHGRI Funds Large-Scale Sequencing Centers


October 16, 2006

NIH Announces Two Integral Components of The Cancer Genome Atlas Pilot Project



September 13, 2006

National Institutes of Health to Map Genomic Changes of Lung, Brain, and Ovarian Cancers



December 13, 2005

NIH Launches Comprehensive Effort to Explore Cancer Genomics

In the News

Featured Articles
Genome Surveys Reveal Complexity of Brain Cancers
September 9, 2008
NCI Cancer Bulletin
Volume 5 / Number 18
This NCI Cancer Bulletin article features one of the most comprehensive studies to date of the molecular changes underlying brain cancer. The TCGA Research Network analyzed 206 glioblastoma (GBM) brain tumors using an integrated approach based on multiple types of genetic data and clinical information. Highlighting three genes found in the disease – ERBB2, NF1, and TP53, these findings significantly expand our current knowledge about the genetic networks involved in this deadly disease and potential therapeutic strategies.

Comprehensive genomic characterization defines human glioblastoma genes and core pathways
September 4, 2008
The Cancer Genome Atlas Research Network reported the first results of its large-scale, comprehensive study of the most common form of brain cancer, glioblastoma (GBM) in the Sept. 4, 2008 advance online edition of the journal Nature. Among the TCGA findings are the identification of many gene mutations involved in GBM, including three previously unrecognized mutations that occur with significant frequency; and the delineation of core pathways disrupted in this type of brain cancer. One of the most exciting results is an unexpected observation that points to a potential mechanism of resistance to a common chemotherapy drug used for brain cancer.

TCGA Moving Molecular Oncology Forward
May 2008
NCI Cancer Bulletin
Dr. Daniela S. Gerhard, director of the Office of Cancer Genomics, reviews the progress of The Cancer Genome Atlas (TCGA) pilot project with molecular oncology advances seen through international data sharing among researchers in addition to tools and technologies being developed to enable researchers to delve further into the molecular machinery of cancer.

Mapping the Cancer Genome
Scientific American
March 2007
Francis S. Collins, director of the National Human Genome Research Institute, and Anna D. Barker, deputy director for Advanced Technologies and Strategic Partnerships at the National Cancer Institute, discuss the importance of creating a comprehensive catalogue of the genomic changes involved in cancer through The Cancer Genome Atlas (TCGA).

News Conference
The Cancer Genome Atlas Launch
December 13, 2005
National Press Club
Washington, D.C.

National Cancer InstituteNational Human Genome Research InstituteNational Institutes of HealthDepartment of Health and Human